Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07092605 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures

Name: Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures — clinical trial record (NCT07092605)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusEnrolling by Invitation

PhaseEarly Phase 1

SponsorAgelessRx

Started2024-11-01

View on ClinicalTrials.gov ↗

Record status

This record was last updated July 30, 2025 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.

AgelessRx

3 trials monitored

See all monitored trials

Obesity

3,530 trials monitored

See 136 trials at risk

The goal of this clinical study has two objectives. The Primary Objective is to evaluate the effectiveness of microdosed GLP-1 receptor agonists in improving measures of health, quality of life, and longevity. The Secondary Objective: To assess the impact of these therapies on weight management practices and metabolic health.

Trial Details

NCT Number	NCT07092605
Lead Sponsor	AgelessRx
Conditions	Longevity, Quality of Life, Mood, Inflammation, Immune Health, Pain Management, Weight Management, Alertness
Enrollment	150 participants
Start Date	2024-11-01
Primary Completion	2025-11-01 (estimated)
Study Completion	2025-12-01 (estimated)
Updated on ClinicalTrials.gov	2025-07-30